GLP-1 therapies may also increase the risk of pancreatitis, although this concern seems to have abated in the last 2 years [36,37,38,39]
You may be a strong candidate if you meet the following criteria: BMI of 25 or higher No history of eating disorders (such as anorexia, bulimia, binge eating, or emotional eating) No personal or family history of thyroid cancer or Multiple Endocrine Neoplasia type 2 (MEN 2) No history of diabetic retinopathy Not currently taking any other form of GLP-1 18 years or older Not pregnant or breastfeeding Our medical team will review your full health history during your consultation to ensure the program is safe and appropriate for you
No completed randomized controlled human trials exist for any indication as of 2026
The pill must be swallowed whole and cannot be split, crushed, chewed, or dissolved
To further evaluate whether altered cytokine expression may affect the cytokine secretion into the media, the levels of these cytokines were measured in the conditioned media of treated groups
The physiology of glucagon-like peptide 1. Physiological Reviews, 2007